At Haematex our interest is to develop and provide better laboratory methods for investigating blood clotting and bleeding disorders.


Thrombosis and haemorrhage affect many clinical decisions and their control can impact treatment outcomes and indeed life itself. In our view, most coagulation screening tests these days are precise but lack clinical specificity. Our Australian R&D activity is supported by distributorships for and synergies with selected diagnostic suppliers. We unreservedly guarantee the quality of all the products which we distribute and manufacture and offer competitive prices.